More about

Head And Neck Cancer

News
June 09, 2022
6 min watch
Save

Acupuncture benefits patients with radiation-induced xerostomia

Acupuncture benefits patients with radiation-induced xerostomia

Acupuncture benefitted patients with head and neck cancer who had radiation-induced xerostomia, according to study results presented at ASCO Annual Meeting.

News
June 09, 2022
2 min read
Save

Sequential pembrolizumab may be optimal timing with chemoradiotherapy in head/neck cancer

Sequential pembrolizumab may be optimal timing with chemoradiotherapy in head/neck cancer

CHICAGO — A sequential schedule of fixed-dose pembrolizumab with chemoradiotherapy conferred numerically higher PFS rates vs. concurrent timing of the drug among patients with locally advanced head and neck cancer, study results showed.

News
June 05, 2022
2 min read
Save

Docetaxel plus radiation new standard of care in cisplatin-ineligible head and neck cancer

Docetaxel plus radiation new standard of care in cisplatin-ineligible head and neck cancer

CHICAGO — Docetaxel prolonged DFS and OS when added to radiation for cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, according to study results presented at ASCO Annual Meeting.

News
June 03, 2022
2 min read
Save

Radiotherapy comparable to concurrent chemoradiotherapy in nasopharyngeal cancer subset

Radiotherapy comparable to concurrent chemoradiotherapy in nasopharyngeal cancer subset

CHICAGO — Intensity-modulated radiotherapy conferred disease control and survival outcomes comparable to concurrent chemoradiotherapy but with less toxicity among patients with low-risk nasopharyngeal carcinoma, according to study results.

News
May 28, 2022
4 min watch
Save

Health technology may help people with cancer quit smoking

Health technology may help people with cancer quit smoking

The inclusion of a smoking cessation tool into electronic health records increased self-reported patient quit rates by more than 5 percentage points, according to study results.

News
May 12, 2022
2 min read
Save

Entrectinib induces durable, intracranial responses in NTRK fusion-positive solid tumors

Entrectinib induces durable, intracranial responses in <i>NTRK</i> fusion-positive solid tumors

Entrectinib demonstrated durable systemic and intracranial responses in patients with NTRK fusion-positive solid tumors, according to study results published in Clinical Cancer Research.

News
May 12, 2022
2 min read
Save

Capecitabine maintenance extends PFS in newly diagnosed metastatic nasopharyngeal carcinoma

Capecitabine maintenance extends PFS in newly diagnosed metastatic nasopharyngeal carcinoma

Capecitabine maintenance therapy significantly prolonged PFS among patients with newly diagnosed metastatic nasopharyngeal carcinoma who achieved disease control after capecitabine-containing induction chemotherapy, according to a study.

News
May 11, 2022
2 min read
Save

Safety of paclitaxel-based regimens varies among patients with esophageal cancer

Safety of paclitaxel-based regimens varies among patients with esophageal cancer

Paclitaxel plus fluorouracil did not demonstrate OS superiority over paclitaxel plus cisplatin or paclitaxel plus carboplatin in definitive chemoradiation for locally advanced esophageal squamous cell carcinoma.

News
May 02, 2022
3 min read
Save

Extranodal extension linked to shorter survival in oral cavity cancer

Extranodal extension linked to shorter survival in oral cavity cancer

DALLAS — Microscopic extranodal extension appeared associated with shorter survival among patients with oral cavity squamous cell carcinoma, according to study results.

News
May 02, 2022
2 min read
Save

Treatment for HPV-positive oropharyngeal cancer varies by facility type

Treatment for HPV-positive oropharyngeal cancer varies by facility type

DALLAS — Treatment modality for HPV-positive oropharyngeal squamous cell carcinoma varied considerably by facility type, according to study results.

View more